World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
88
Citations
32863
World Ranking
1153
National Ranking
612

Alfred E. Chang publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Alfred E. Chang sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 357 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Alfred E. Chang D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Alfred E. Chang sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 88 D-Index — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Best Publications

  • A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

    Steven A. Rosenberg;Michael T. Lotze;Linda M. Muul;Alfred E. Chang

  • Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

    Steven A. Rosenberg;Michael T. Lotze;Linda M. Muul;Susan Leitman

  • Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans

    Gary J. Nabel;Elizabeth G. Nabel;Zhi Yong Yang;Bernard A. Fox

  • Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

    Ilona Kryczek;Mousumi Banerjee;Pui Cheng;Linhua Vatan

  • Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study.

    S L Topalian;D Solomon;F P Avis;A E Chang

  • Cutting Edge: Th17 and Regulatory T Cell Dynamics and the Regulation by IL-2 in the Tumor Microenvironment

    Ilona Kryczek;Shuang Wei;Linhua Zou;Saleh Altuwaijri

  • Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis.

    Christina M. Coughlin;Kevin E. Salhany;Maria Wysocka;Etsuko Aruga

  • Vaccination Of Pediatric Solid Tumor Patients with Tumor Lysate-pulsed Dendritic Cells Can Expand Specific T Cells and Mediate Tumor Regression

    James D. Geiger;Raymond J. Hutchinson;Lyndon F. Hohenkirk;Elizabeth A. McKenna

  • Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA–liposome complexes

    Gary J. Nabel;David Gordon;D. Keith Bishop;Brian J. Nickoloff

  • IL-17+ Regulatory T Cells in the Microenvironments of Chronic Inflammation and Cancer

    Ilona Kryczek;Ke Wu;Ende Zhao;Shuang Wei

  • Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2.

    Hirohisa Yoshizawa;Alfred E. Chang;Suyu Shu

  • Cancer stem cell vaccination confers significant antitumor immunity

    Ning Ning;Qin Pan;Qin Pan;Fang Zheng;Fang Zheng;Seagal Teitz-Tennenbaum

  • A Phase I Trial of Tumor Lysate-pulsed Dendritic Cells in the Treatment of Advanced Cancer

    Alfred E. Chang;Bruce G. Redman;Joel R. Whitfield;Brian J. Nickoloff

  • Myeloid-Derived Suppressor Cells Endow Stem-like Qualities to Breast Cancer Cells through IL6/STAT3 and NO/NOTCH Cross-talk Signaling

    Dongjun Peng;Takashi Tanikawa;Wei Li;Lili Zhao

  • Immunologic response to cryoablation of breast cancer

    Michael S. Sabel;Matthew A. Nehs;Gang Su;Kathleen P. Lowler

  • Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2.

    A E Chang;A Aruga;M J Cameron;V K Sondak

  • Radiotherapy potentiates the therapeutic efficacy of intratumoral dendritic cell administration.

    Seagal Teitz-Tennenbaum;Qiao Li;Susan Rynkiewicz;Fumito Ito

  • Current Status and Future Directions

    Unknown

  • The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.

    Sandra C. Paek;Kent A. Griffith;Timothy M. Johnson;Vernon K. Sondak

  • FOXP3 defines regulatory T cells in human tumor and autoimmune disease

    Ilona Kryczek;Rebecca Liu;Guobin Wang;Ke Wu

Frequent Co-Authors

Steven A. Rosenberg
Steven A. Rosenberg National Institutes of Health
Suyu Shu
Suyu Shu University of Michigan–Ann Arbor
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
Timothy J. Kinsella
Timothy J. Kinsella Brown University
Max S. Wicha
Max S. Wicha University of Michigan–Ann Arbor
Vernon K. Sondak
Vernon K. Sondak University of South Florida
James J. Mulé
James J. Mulé University of South Florida
Weiping Zou
Weiping Zou University of Michigan–Ann Arbor
Susan F. Leitman
Susan F. Leitman National Institutes of Health
Suzanne L. Topalian
Suzanne L. Topalian Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Alfred E. Chang

Recently Published Articles